The role of the catechol-o-methyltransferase (COMT) gene in personality and related psychopathological disorders

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 3, 2012, Pages 236-250

  Montag, Christian ^a   Jurkiewicz, Magdalena ^b   Reuter, Martin ^a  

^a UNIVERSITY OF BONN   (Germany)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Anxiety; Anxiety disorders; Catechol o methyltransferase; COMT Val158met; Dopamine; Genetic imaging; Personality

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE;

ANXIETY; ANXIETY DISORDER; AVOIDANCE BEHAVIOR; BEHAVIOR CONTROL; CHARACTER STATE; CONCEPTUAL FRAMEWORK; DOPAMINERGIC TRANSMISSION; EMOTIONALITY; EPIGENETICS; EXTRAVERSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; INHIBITION (PSYCHOLOGY); INTROVERSION; MENTAL DISEASE; NEUROSIS; NONHUMAN; PANIC; PERSONALITY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGICAL THEORY; QUESTIONNAIRE; REINFORCEMENT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERAMENT;

EID: 84861744128     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712800672382     Document Type: Review

References (112)

1. Allport, G.W. Pattern and growth in personality. New York: Holt, Rinehart and Winston, 1961. (cited after Maltby, J.; Day, L.; and Macaskill, A. Personality, Individual Differences and Intelligence. Pearson: Essex, 2007, p. 7.)
2. Steyer, R.; Schmitt, M.; Eid, M. Latent state-trait theory and research in personality and individual differences. Eur. J. Pers., 1999, 13(5), 389-408.
3. Cattell, R.B. Personality: A systematic, theoretical, and factual study. New York: McGraw-Hill, 1950.
4. Kendler, K.S.; Gatz, M.; Gardner, C.O.; Pedersen, N.L. Personality and major depression: a Swedish longitudinal, population-based twin study. Arch. Gen. Psychiatry, 2006, 63(10), 1113-1120.
5. Eley, T.C.; Tahir, E.; Angleitner, A.; Harriss, K.; McClay, J.; Plomin, R.; Riemann, R.; Spinath, F.; Craig I. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2003, 120B(1), 90-96.
6. Eysenck, H.J. The biological basis of personality. Springfield, Ill: Charles C. Thomas, 1967.
7. Maltby, J.; Day, L.; Macaskill, A. Personality, Individual Differences and Intelligence. Pearson: Essex, 2007, p. 200.
8. McCann, S.J. Suicide, big five personality factors, and depression at the American state level. Arch. Suicide Res., 2010, 14(4), 368-374.
9. Eysenck, M.W. Extraversion, activation and the recall of prose. Br. J. Psychol., 1976, 67(1), 53-61.
10. Vogel, F.; Schalt, E. The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. III. Interpretation of the results. Hum. Genet., 1979, 47(1), 81-111.
11. Beauducel, A.; Brocke, B.; Leue, A. Energetical bases of extraversion: effort, arousal, EEG, and performance. Int. J. Psychophysiol., 2006, 62(2), 212-223.
12. Eysenck, H.J.; Eysenck, M.W. The manual to the Eysenck-Personality Inventory. San Diego: Educational and Industrial Testing Service, 1968.
13. Gray, J.A. The psychophysiological basis of introversion-extraversion. Behav. Res. Ther., 1970, 8(3), 249-266.
14. Gray, J.; McNaughton, N. The Neuropsychology of Anxiety. Oxford Press: Oxford, UK, 2000.
15. Carver, C.S.; White, T.L. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS scales. J. Pers. Soc. Psychol., 1994, 67(2), 319-333.
16. Jackson, C.J. Jackson-5 Scales of revised Reinforcement Sensitivity Theory (r-RST) and their application to dysfunctional real world outcomes. J. Res. Pers., 2009, 43(4), 556-569.
17. Leue, A.; Beauducel, A. A Meta-Analysis of Reinforcement Sensitivity Theory: On performance parameters in reinforcement tasks. Pers. Soc. Psychol. Rev., 2008, 12(4), 353-369.
18. Matthews, G.; Gilliland, K. The personality theories of H.J. Eysenck and J.A. Gray: a comparative review. Pers. Ind. Diff., 1999, 26(4), 583-626.
19. Cloninger, C.R.; Svrakic, D.M.; Przybeck, T.R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry, 1993, 50(12), 975-990.
20. Kose, S. Psychobiological Model of Temperament and Character. Yeni Symposium, 2003, 41(2), 86-97.
21. Ando, J.; Ono, Y.; Yoshimura, K.; Onoda, N.; Shinohara, M.; Kanba, S.; Asai, M. The genetic structure of Cloninger's seven factor model of temperament and character in a Japanese sample. J. Pers., 2002, 70(5), 583-609.
22. Ando, J.; Suzuki, A.; Yamagata, S.; Kijima, N.; Maekawa, H.; Ono, Y.; Jang, K.L. Genetic and environmental structure of Cloninger's temperament and character dimensions. J. Pers. Disord., 2004, 18(4), 379-393.
23. Montag, C.; Markett, S.; Basten, U.; Stelzel, C.; Fiebach, C.; Canli, T.; Reuter, M. Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts Novelty Seeking and Harm Avoidance. Neuropsychopharmacology, 2010, 35(9), 1860-1867.
24. Panksepp, J. Affective Neuroscience. Oxford University Press: London, 1998, pp. 187-205.
25. Davis, K.L.; Panksepp, J.; Normansell, L. The affective neuroscience personality scales: normative data and implications. Neuropsychoanalysis, 2003, 5(1), 57-69.
26. Costa, P.T., Jr.; McCrae, R.R. Normal personality assessment in clinical practice: The NEO Personality Inventory. Psychol. Assess., 1992, 4(1), 5-13.
27. Davis, K.L.; Panksepp, J. The brain's emotional foundations of human personality and the Affective Neuroscience Personality Scales. Neurosci. Biobehav. Rev., 2011, 35(9), 1946-1958.
28. Reuter, M.; Weber, B.; Fiebach, C.J.; Elger, C.; Montag, C. The biological basis of anger: associations with the gene coding for DARPP-32 (PPP1R1B) and with amygdala volume. Behav. Brain Res., 2009, 202(2), 179-183.
29. Montag, C.; Fiebach, C.F.; Kirsch, P.; Reuter, M. Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene OXTR influences negative emotionality. Biol. Psychiatry, 2011, 69(6), 601-603.
30. Ackerman, P.L.; Heggestad, E.D. Intelligence, personality, and interests: Evidence for overlapping traits. Psychol. Bull., 1997, 121(2), 219-245.
31. Borkenau, P.; Riemann, R.; Angleitner, A.; Spinath, F.M. Genetic and environmental influences on observed personality: evidence from the German Observational Study of Adult Twins. J. Pers. Soc. Psychol., 2001, 80(4), 655-668.
32. Rieman, R.; Angleitner, A.; Strelau, J. Genetic and environmental influences on personality: a study of twins reared together using the self-and peer report NEO-FFI scales. J. Pers., 1997, 65(3), 449-475.
33. Markett, S.; Montag, C.; Reuter, M. The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality. Emotion, 2011, 11(2), 450-455.
34. Caspi, A.; Sugden, K.; Moffitt, T.E.; Taylor, A.; Craig, I.W.; Harrington, H.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 2003, 301(5631), 386-389.
35. Plomin, R.; Haworth, C.M.; Davis, O.S. Common disorders are quantitative traits. Nat. Rev. Genet., 2009, 10(12), 872-878.
36. Terracciano, A.; Sanna, S., Uda, M.; Deiana, B.; Usala, G.; Busonero, F.; Maschio, A.; Scally, M.; Patriciu, N.; Chen, W.M.; Distel, M.A.; Slagboom, E.P.; Boomsma, D.I.; Villafuerte, S.; Sliwerska, E.; Burmeister, M.; Amin, N.; Janssens, A.C.; van Duijn, C.M.; Schlessinger, D.; Abecasis, G.R.; Costa, P.T., Jr. Genome-wide association scan for five major dimensions of personality. Mol. Psychiatry, 2010, 15(6), 647-656.
37. Chen, Z.Y.; Jing, D.; Bath, K.G.; Ieraci, A.; Khan, T.; Siao, C.J.; Herrera, D.G.; Toth, M.; Yang, C.; McEwen, B.S.; Hempstead, B.L.; Lee, F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science, 2006, 314(5796), 140-143.
38. Montag, C.; Basten U.; Stelzel, C.; Fiebach, C.J.; Reuter, M. The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in-studies from a genetic association study in humans. Psychiatry Res., 2010, 179(1), 86-90.
39. Ross, S.A.; Wong, J.Y.; Clifford, J.J.; Kinsella, A.; Massalas, J.S.; Horne, M.K.; Scheffer, I.E.; Kola, I.; Waddington, J.L.; Berkovic, S.F.; Drago, J. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J. Neurosci., 2000, 20(17), 6431-6441.
40. Wise, R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci., 2004, 5(6), 483-494.
41. Depue, R.A.; Luciana, M.; Arbisi, P.; Collins, P.; Leon, A. Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J. Pers. Soc. Psychol., 1994, 67(3), 485-498.
42. Reuter, M.; Schmitz, A.; Corr, P.; Hennig, J. Molecular genetics support Gray's personality theory: the interaction of COMT and DRD2 polymorphisms predicts the behavioural approach system. Int. J. Neuropsychopharmacol., 2006, 9(2), 155-166.
43. Felten, A.; Montag, C.; Markett, S.; Walter, N.T.; Reuter, M. Genetically determined dopamine availability predicts disposition for depression. Brain Behav., 1(2), 109-118.
44. Nagatsu, T.; Levitt, M.; Udenfriend, S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem., 1964, 239, 2910-2917.
45. Lovenberg, W.; Weissbach, H.; Udenfriend, S. Aromatic L-amino acid decarboxylase. J. Biol. Chem., 1962, 237, 89-93.
46. Rosengren, E. On the role of monoamine oxidase for the inactivation of dopamine in brain. Acta Physiol. Scand., 1960, 49(4), 370-375.
47. Axelrod, J.; Senoh, S.; Witkop, B. O-methylation of catechol amines in vivo. J. Biol. Chem., 1958, 233, 697-701.
48. Hennig, J.; Netter, P. Biologische Grundlagen der Persönlichkeit. Elsevier: Heidelberg, 2005, pp.248-249.
49. Opmeer, E.M.; Kortekaas, R.; Aleman, A. Depression and the role of genes involved in dopamine metabolism and signalling. Prog. Neurobiol., 2010, 92(2), 112-133.
50. Grossman, M.H.; Emanuel, B.S.; Budarf, M.L. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics, 1992, 12(4), 822-825.
51. Lachman, H.M.; Papolos, D.F.; Saito, T.; You, Y.-M.; Szumlanski, C.L.; Weinshilboum, R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 1996, 6(3), 243-250.
52. Lewis, D.A.; Melchitzky, D.S.; Sesack, S.R.; Whitehead, R.E.; Auh, S.; Sampson, A. Dopamine transporter immunioreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol., 2001, 432(1), 119-136.
53. Tenhunen, J.; Salminen, M.; Lundström, K.; Kiviluoto, T.; Savolainen, R.; Ulmanan, I. Genomic organization of the human catechol-o-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem., 1994, 223(3), 1049-1059.
54. Terracciano, A.; Tanaka, T.; Sutin, A.R.; Deiana, B.; Balaci, L.; Sanna, S.; Olla, N.; Maschio, A.; Uda, M.; Ferrucci, L.; Schlessinger, D.; Costa, P.T., Jr. BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology, 2010, 35(5), 1083-1089.
55. Enoch, M.A.; Schuckit, M.A.; Johnson, B.A.; Goldman, D. Genetics of alcoholism using intermediate phenotypes. Alcohol Clin. Exp. Res., 2003, 27(2), 169-176.
56. Enoch, M.A.; White, K.V.; Waheed, J.; Goldman, D. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress. Anxiety, 2008, 25(5), 383-392.
57. Hashimoto, R.; Noguchi, H.; Hori, H.; Ohi, K.; Yasuda, Y.; Takeda, M.; Kunugi, H. A possible association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and the personality trait of harm avoidance in Japanese healthy subjects. Neurosci. Lett., 2007, 428(1), 17-20.
58. Reuter, M.; Hennig, J. Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. Neuroreport, 2005, 16(10), 1135-1138.
59. Tsai, S.J.; Hong, C.J.; Yu, Y.W.; Chen, T.J. Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young chinese females. Neuropsychobiology, 2004, 50(2), 153-156.
60. Chen, C.; Chen, C.; Moyzis, R.; Dong, Q.; He, Q.; Zhu, B.; Li, J.; Li, H.; Li, J.; Lessard, J. Sex Modulates the Associations Between the COMT Gene and Personality Traits. Neuropsychopharmacology, 2011, 36(8), 1593-1598.
61. Hosák, L.; Libiger, J.; Cizek, J.; Beránek, M.; Cermáková, E. The COMT Val158Met polymorphism is associated with novelty seeking in Czech methamphetamine abusers: preliminary results. Neuroendocrinol. Lett., 2006, 27(6), 799-802.
62. Kim, S.J.; Kim, Y.S.; Kim, S.Y.; Lee, H.S.; Kim, C.H. An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans. Neurosci. Lett., 2006, 401(1-2), 154-158.
63. Ishii, G.; Suzuki, A.; Oshino, S.; Shiraishi, H.; Matsumoto, Y.; Otani, K.; Goto, K. Association study of catechol-O-methyltransferase Val158Met polymorphism with personality traits in Japanese healthy volunteers. Eur. Psychiatry, 2007, 22(7), 462-465.
64. Mikoajczyk, E.; Grzywacz, A.; Samochowiec, J. The association of catechol-O-methyltransferase genotype with the phenotype of women with eating disorders. Brain Res., 2010, 1307, 142-148.
65. Reuter, M.; Frenzel, C.; Walter, N.T.; Markett, S.; Montag, C. Investigating the genetic basis of altruism: the role of the COMT Val158Met polymorphism. Soc. Cogn. Affect. Neurosci., 2011, 6(5), 662-668.
66. Drabant, E.M.; Hariri, A.R.; Meyer-Lindenberg, A.; Munoz, K.E.; Mattay, V.S.; Kolachana, B.S.; Egan, M.F.; Weinberger, D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry, 2006, 63(12), 1396-1406.
67. Hamidovic, A.; Dlugos, A.; Palmer, A.A.; de Wit, H. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatry Genet., 2010, 20(3), 85-92.
68. Montag, C.; Buckholtz, J.W.; Hartmann, P.; Merz, M.; Burk, C.; Hennig, J.; Reuter, M. COMT genetic variation affects fear processing: psychophysiological evidence. Behav. Neurosci., 2008, 122(4), 901-909.
69. Cerasa, A.; Gioia, M.C.; Tarantino, P.; Labate, A.; Arabia, G.; Annesi, G.; Lanza, P.; Di Palma, G.; Blasi, V.; Quattrone, A. The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals. Genes Brain Behav., 2009, 8(4), 459-463.
70. Montag, C.; Weber, B.; Jentgens, E.; Elger, C.; Reuter, M. An epistasis effect of functional variants on the BDNF and DRD2 genes modulates gray matter volume of the anterior cingulate cortex in healthy humans. Neuropsychologia, 2010c, 48(4), 1016-1021.
71. Jönsson, E.G.; Nöthen, M.M.; Grünhage, F.; Farde, L.; Nakashima, Y.; Propping, P.; Sedvall, G.C. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry, 1999, 4(3), 290-296.
72. Light, K.J.; Joyce, P.R.; Luty, S.E.; Mulder, R.T.; Carter, J.D.; Frampton, C.M.; Miller, A.L.; Kennedy, M.A. An association study of DRD2 and COMT polymorphisms with novelty seeking and harm avoidance scores, in two independent samples of depressed patients. Behav. Brain Funct., 2007, 3, 3.
73. Heinz, A.; Goldman, D.; Jones, D.W.; Palmour, R.; Hommer, D.; Gorey, J.G.; Lee, K.S.; Linnoila, M.; Weinberger, D.R. Genotype influences in vivo DAT availability in human striatum. Neuropsychopharmacology, 2000, 22(2), 133-139.
74. Costa, A.; Riedel, M.; Müller, U.; Möller, H.J.; Ettinger, U. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Synapse, 2011, 65(10), 998-1005.
75. Quednow, B.B.; Schmechtig, A.; Ettinger, U.; Petrovsky, N.; Collier, D.A.; Vollenweider, F.X.; Wagner, M.; Kumari, V. Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biol. Psychiatry, 2009, 66(6), 614-620.
76. Goldman, D.; Oroszi, G.; Ducci, F. The genetics of addictions: uncovering the genes. Nat. Rev. Genet., 2005, 6(7), 521-532.
77. Zubieta, J.K.; Heitzeg, M.M.; Smith, Y.R.; Bueller, J.A.; Xu, K.; Xu, Y.; Koeppe, R.A.; Stohler, C.S.; Goldman, D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 2003, 299(5610), 1240-1243.
78. Valente, N.L.; Vallada, H.; Cordeiro, Q.; Bressan, R.A.; Andreoli, S.B.; Mari, J.J., Mello, M.F. Catechol-O-methyltransferase (COMT) val158met polymorphism as a risk factor for PTSD after urban violence. J. Mol. Neurosci., 2011, 43(3), 516-523.
79. Kolassa, I.T.; Kolassa, S.; Ertl, V.; Papassotiropoulos, A.; De Quervain, D.J. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val (158)Met polymorphism. Biol. Psychiatry, 2010, 67(4), 304-308.
80. Samochowiec, J.; Hajduk, A.; Samochowiec, A.; Horodnicki, J.; Stepie, G.; Grzywacz, A.; Kucharska-Mazur, J. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res., 2004, 128(1), 21-26.
81. Zalsman, G.; Huang, Y.Y.; Oquendo, M.A.; Brent, D.A.; Giner, L.; Haghighi, F.; Burke, A.K.; Ellis, S.P.; Currier, D.; Mann, J.J. No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders. Arch. Suicide Res., 2008, 12(4), 327-335.
82. Domschke, K.; Ohrmann, P.; Braun, M.; Suslow, T.; Bauer, J.; Hohoff, C.; Kersting, A.; Engelien, A.; Arolt, V.; Heindel, W.; Deckert, J.; Kugel, H. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res., 2008, 163(1), 13-20.
83. Goldman, D. Gene x environment interactions in complex behavior: First, build a telescope. Biol. Psychiatry, 2010, 67(4), 295-296.
84. Buckholtz, J.W.; Meyer-Lindenberg, A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci., 2008, 31(3), 120-129.
85. De Geus, E.; Goldberg, T.; Boomsma, D.I.; Posthuma, D. Imaging the genetics of brain structure and function. Biol. Psychol., 2008, 79(1), 1-8.
86. Mier, D.; Kirsch, P.; Meyer-Lindenberg, A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry, 2010, 15(9), 918-927.
87. Rasch, B.; Spalek, K.; Buholzer, S.; Luechinger, R.; Boesiger, P.; de Quervain, D.J.; Papassotiropoulos, A. Aversive stimuli lead to differential amygdala activation and connectivity patterns depending on catechol-O-methyltransferase Val158Met genotype. Neuroimage, 2010, 52(4), 1712-1719.
88. Heinz, A.; Smolka, M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci., 2006, 17(3), 359-367.
89. Honea, R.; Verchinski, B.A.; Pezawas, L.; Kolachana, B.S.; Callicott, J.H.; Mattay, V.S.; Weinberger, D.R.; Meyer-Lindenberg, A. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage, 2009, 45(1), 44-51.
90. Ho, B.C.; Wassink, T.H.; O'Leary, D.S.; Sheffield, V.C.; Andreasen, N.C. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol. Psychiatry, 2005, 10(3), 229, 287-298.
91. Zinkstok, J.; Schmitz, N.; van Amelsvoort, T.; de Win, M.; van den Brink, W.; Baas, F.; Linszen, D. The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci. Lett., 2006, 405(1-2), 34-39.
92. Bilder, R.M.; Volavka, J.; Lachman, H.M.; Grace, A.A. The catechol-O-methyltransferase polymorphism: relations to the tonicphasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology, 2004, 29(11), 1943-1961.
93. Meaney, M.J.; Ferguson-Smith, A.C. Epigenetic regulation of the neural transcriptome: the meaning of the marks. Nat. Neurosci., 2010, 13(11), 1313-1318.
94. Apud, J.A.; Weinberger, D.R. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs, 2007, 21(7), 535-557.
95. Tunbridge, E.M.; Harrison, P.J.; Weinberger, D.R. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry, 2006, 60(2), 141-151.
96. Schürhoff, F.; Szöke, A.; Chevalier, F.; Roy, I.; Méary, A.; Bellivier, F.; Giros, B.; Leboyer, M. Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. Am. J. Med. Genet.B. Neuropsychiatr. Genet., 2007, 144B(1), 64-68.
97. Docherty, A.R.; Sponheim, S.R. Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia. J. Abnorm. Psychol., 2008, 117(4), 788-798.
98. Aoki, J.; Iwahashi, K.; Ishigooka, J.; Ikeda, K. Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI. Psychiatry Res., 2011, 187(1-2), 312-313.
99. Wray, N.R.; James, M.R.; Dumenil, T.; Handoko, H.Y.; Lind, P.A.; Montgomery, G.W.; Martin, N.G. Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2008, 147B(7), 1314-1318.
100. Sheldrick, A.J.; Krug, A.; Markov, V.; Leube, D.; Michel, T.M.; Zerres, K.; Eggermann, T.; Kircher, T. Effect of COMT val158met genotype on cognition and personality. Eur. Psychiatry, 2008, 23(6), 385-389.
101. Hoth, K.F.; Paul, R.H.; Williams, L.M.; Dobson-Stone, C.; Todd, E.; Schofield, P.R.; Gunstad, J.; Cohen, R.A.; Gordon, E. Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults. Neuropsychiatr. Dis. Treat., 2006, 2(2), 219-225.
102. Tochigi, M.; Otowa, T.; Hibino, H.; Kato, C.; Otani, T.; Umekage, T.; Utsumi, T.; Kato, N.; Sasaki T. Combined analysis of association between personality traits and three functional polymorphisms in the tyrosine hydroxylase, monoamine oxidase A, and catechol-O-methyltransferase genes. Neurosci. Res., 2006, 54(3), 180-185.
103. Stein, M.B.; Fallin, M.D.; Schork, N.J.; Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology, 2005, 30(11), 2092-2102.
104. Olsson, C.A.; Anney, R.J.; Lotfi-Miri, M.; Byrnes, G.B.; Williamson, R.; Patton, G.C. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr. Genet., 2005, 15(2), 109-115.
105. Gadow, K.D.; Roohi, J.; DeVincent, C.J.; Kirsch, S.; Hatchwell, E. Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder. J. Autism Dev. Disord., 2009, 39(11), 1542-1551.
106. Katerberg, H.; Cath, D.C.; Denys, D.A.; Heutink, P.; Polman, A.; van Nieuwerburgh, F.C.; Deforce, D.L.; Bochdanovits, Z.; van Balkom, A.J.; den Boer, J.A. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2010, 153B(1), 167-176.
107. Maron, E.; Tõru, I.; Tasa, G.; Must, A.; Toover, E.; Lang, A.; Vasar, V.; Shlik, J. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers. Neurosci. Lett., 2008, 446(2-3), 88-92.
108. Baekken, P.M.; Skorpen, F.; Stordal, E.; Zwart, J.A.; Hagen K. Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT). BMC Psychiatry, 2008, 8, 48.
109. Hettema, J.M.; An, S.S.; Bukszar, J.; van den Oord, E.J.; Neale, M.C.; Kendler, K.S.; Chen X. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol. Psychiatry, 2008, 64(4), 302-310.
110. Lochner, C.; Hemmings, S.M.; Kinnear, C.J.; Nel, D.; Hemmings, S.M.; Seedat, S.; Moolman-Smook, J.C.; Stein, D.J. Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes. Isr. J. Psychiatry Relat. Sci., 2008, 45(3), 164-176.
111. Funke, B.; Malhotra, A.K.; Finn, C.T.; Plocik, A.M.; Lake, S.L.; Lencz, T.; DeRosse, P.; Kane, J.M.; Kucherlapati, R. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav. Brain Funct., 2005, 1, 19.
112. Poyurovsky, M.; Michaelovsky, E.; Frisch, A.; Knoll, G.; Amir, I.; Finkel, B.; Buniak, F.; Hermesh, H.; Weizman, R. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci. Lett., 2005, 389(1), 21-24.